•  
  •  
  •  

Sopharma AD

Summary

Company ID (NIN)

831902088

Company owner / manager

  • Telekomplekt Invest AD
  • Donev Investments Holding AD
  • Other
  • Romfarm Company OOD
  • Individuals

Country

Bulgaria

Capital

134,798,000

Total assets

574,770,000

Net profit for the period

37,770,000

Report year

2016

Currency

BGN

Industry

Pharmaceuticals

Southeastern Europe Company Index (SEECI)

What is SEECI?

General information

About Sopharma AD

Sopharma AD is a Bulgarian pharmaceuticals manufacturer.

The company is included in:

  • the indexes:
    • on the Bulgarian Stock Exchange
      • SOFIX
      • BGBX40
      • BGTR30
    • Dow Jones STOXX EU Enlarged Total Market Index (TMI)
    • Dow Jones STOXX Balkan 50 Equal Weighted Index

 

Last updated on Oct 27, 2017.

 

Meta info
Status
Active
Legal form
Joint Stock Company
Incorporation date
Jan. 1, 1933
NIN
831902088
Tickers
3JR
Stock Exchange
Bulgarian Stock Exchange
ISIN
BG11SOSOBT18
Profile last updated
Oct. 27, 2017, 3:31 p.m.
Alternative names

    Sopharma JSC;
    Sofarma AD (JSC);
    Sopharma PLC

History

    1933 – Bulgarian business organisation Balgarsko Aptekarsko Kooperativno Druzhestvo establishes the first drug producing laboratory in Sofia, the capital of Bulgaria.

    1942 – The drug producing laboratory of Balgarsko Aptekarsko Kooperativno Druzhestvo transforms into pharmaceutical factory Galenus.

    1953 – Galenus is nationalised and changes its name to Himiko-farmatsevtichen Zavod.

    Feb 27, 1990 – State-owned pharmaceutical company Pharmatsia AD, Dupnitsa, Bulgaria, establishes its pharmaceutical subsidiary Sopharma, with a capital of BGL 34,061,000, based in Sofia.

    June 28, 1991 – State-owned company DF Sopharma is established in Sofia as a successor of Pharmatsia's subsidiary Sopharma, assuming its assets and liabilities.

    Nov 15, 1991 – DF Sopharma transforms into a limited liability company with a subscribed capital of BGL 175,659,000.

    Apr 14, 1994 – Sopharma EOOD transforms into a joint stock company, fully owned by the state, with a subscribed capital of BGL 928,171,000.

    May 18, 1995 - Sopharma EAD and other companies establish consortium Pharmindustria AD in Razgrad, northeastern Bulgaria, in which Sopharma AD has a 12.5% stake. The newly founded company specialises in market research.

    June 25, 1996 – Sopharma EAD takes over Sofia-based Nivalinpharma EOOD, engaged in research and development of phytochemicals.

    Apr 25, 1997 – Sopharma AD establishes US-based Sopharma USA JSC, involved in trade in pharmaceuticals and food supplements.

    Dec 31, 1997 – A total of 10.02% of Sopharma AD is privatised via mass privatisation.

    1998 – Sopharma AD increases its subscribed capital to BGL 942,717,000 from BGL 928,171,000.

    May 10, 1999 – Sopharma AD lists on the Bulgarian Stock Exchange.

    June 25, 1999 – The Bulgarian Privatisation Agency sells a 67% stake in Sopharma AD to Irish Nova Technology Company Ltd for USD 32 mln. Later the privatisation contract is cancelled as Nova Technology Company Ltd fails to pay the contracted amount.

    July 27, 2000 – The Bulgarian Privatisation Agency sells 66.94% in Sopharma to pharmaceutical producer Elpharma AD, Sofia, for USD 24 mln.

    Mar 9, 2001 – Sopharma AD increases its subscribed capital to BGN 6.0 mln from BGN 942,717.

    July 27, 2001 – The company acquires a 51% stake in drug producer Rostbalkanpharm ZAO, Russia.

    Nov 27 2001 – The Bulgarian Privatisation Agency sells the remaining 16.32% in Sopharma AD on the Bulgarian Stock Exchange.

    July 25, 2002 – Sopharma AD acquires a 100% stake in pharmaceutical trade company Pharmachim Holding EAD, Sofia, and a 45.89% stake in Sofia-based NIHFI AD, engaged in research and development of pharmaceuticals.

    Aug 15, 2002 – The company acquires a 63.68% stake in trade company Pharmalogistika AD, Sofia.

    Jan 24, 2003 – Sopharma AD acquires a 51% stake in pharmaceutical maker Vramed AD, in Vrabevo, central Bulgaria. In 2005 Sopharma AD sells its stake in Vramed AD.

    July 15, 2003 – Sopharma AD increases its subscribed capital to BGN 66 mln from BGN 6.0 mln.

    Oct 16, 2003 – The company acquires a 60% stake in Polish pharmaceutical trading company Sopharma Poland Sp z.o.o.

    Apr 7, 2004 – Sopharma AD acquires 100% of Medikoaparaturen Zavod, part of medical equipment supplier Meditsinska Technika EAD, Sofia, for BGN 840,000.

    Apr 22, 2004 – Sopharma AD acquires a 49% stake in Balgarska Roza-Sevtopolis AD, a pharmaceutical and cosmetics producer, based in Kazanlak, Bulgaria. In 2007 the company raises its stake in Balgarska Roza-Sevtopolis AD to 49.058%.

    Oct 25, 2004 – The company decreases its stake in Pharmalogistica AD to 43.50% from 63.68%.

    Jan 14, 2005 – Sopharma AD acquires a 9.0% stake in pharmaceutical wholesaler Global Medical OOD, Sofia, which is liquidated in 2007.

    Feb 21, 2005 – The company acquires a 9.99% stake in pharmaceutical wholesaler Kaliman RT AD, in Sofia and a 9.99% stake in pharmaceutical retailer Ceiba-Apteki i Drogerii AD, in Sofia.

    Mar 29, 2005 – Sopharma AD acquires a 9.99% stake in pharmaceutical wholesaler Sanita Trading AD, Sofia.

    July 29, 2005 – Sopharama lists its three-year corporate bonds with a total value of BGN 5.0 mln on the Official Bond Markets of the Bulgarian Stock Exchange.

    Aug 9, 2005 – Sopharma AD acquires a 100% stake in radioactive materials trading company Elektronkomers EOOD, Sofia, for BGN 190,000.

    Oct 13, 2005 – Sopharma AD increases its stake in NIHFI AD to 100%.

    Jan 31, 2006 - Gramercy Emerging Market Fund, based on the Cayman Islands, acquires a 7.58% stake in Sopharma AD.

    Mar 10, 2006– Sopharma AD acquires local infusion solution producer Biopharm Engineering AD.

    Mar 24, 2006 – Sopharma AD and other companies establish real estate investment trust Sopharma Imoti REIT, Sofia, in which Sopharma holds a 4.5% stake.

    Apr 19, 2006 – Sofia-based construction company Telekomplekt AD acquires a 15.76% stake in Sopharma AD.

    Apr 20, 2006 – Elpharma AD sells 48.77% in Sopharma AD. Sofia-based construction company Telekomplekt AD acquires a 15.76% stake in Sopharma AD, trade company Telso AD, Sofia buys a 16.77% stake and Sofia-based commercial bank Sofia AD acquires 16.24%.

    Apr 25, 2006 – Elpharma AD sells further 8.33% in Sopharma AD to construction company Sofstroy AD, Sofia.

    May 3, 2006 – Elpharma AD sells another 12.12% in Sopharma AD to Sofia AD and Telekomplekt AD, which increase their stakes to 25.51% and 21.92%, respectively.

    May 16, 2006 – Elpharma sells further 6.97% in Sopharma AD to Telso AD, which raises its stake to 24.23%.

    June 28, 2006 – Sopharma AD decreases its stake in Sopharma Imoti REIT to 3.46% from 4.5%.

    Oct 26, 2006 – Sopharma AD increases its subscribed capital to BGN 132 mln from BGN 66 mln.

    Nov 9, 2006 – Sopharma AD acquires 28.4% in consultancy company Fintesco AD, Sofia. Later Fintesco AD changes its name to Sopharma Logistica AD.

    Dec 27, 2006 – Sopharma AD acquires 70%  in chemical producer Mineralkomers AD, in Stara Zagora.

    2006 – The company acquires further 68.73% in Sanita Trading AD, raising its stake to 78.72%. Later Sanita Trading changes its name to Sopharma Trading AD.

    June 1, 2007 – Sopharma AD acquires 10.29% in medical devices producer Momina Krepost AD, Veliko Tarnovo, central Bulgaria, increasing its stake to 17.32%.

    June 20, 2007 – Sopharma AD raises its stake in Sopharma Trading AD to 99.62%.

    Aug 14, 2007 – Sopharma AD and other companies establish Sopharma Buildings REIT. Sopharma AD holds 10% in the newly founded company.

    Sept 27, 2007 – Sopharma and Polish pharmaceutical company Natur Produkt Zdrovit Spz o.o. establish Sopharma Zdrovit Spz o.o, in Poland, in which Sopharma holds 50.01%.

    Oct 1, 2007 – The executive board of Sopharma AD approves the company's listing on the Warsaw Stock Exchange.

    October 2007 – Sopharma AD acquires a 50% stake in OAO Vitaminy, Ukraine, engaged in enzymatic agents production.

    Nov 29, 2007 – The company increases its stake in Momina Krepost AD to 44.77%.

    Feb 7, 2008 – Sopharma AD acquires 1.55% in Medica AD, a manufacturer of medical dressing materials, based in Sandanski, southwestern Bulgaria, and raises its stake to 90%. The company also increases its stake in Doverie Obedinen Holding to 23.44%.

    Feb 21, 2008 – The company raises its stake in Momina Krepost to 48.27%.

    Februray 2008 – Sopharma AD raises its stake in OAO Vitaminy to 74.14%.

    Mar 12, 2008 – Sopharma AD acquires 5.01% in textile company Maritsateks AD, Plovdiv.

    Mar 26, 2008 – Sopharma AD acquires a 51% stake in Serbian pharmaceutical producer Ivancic i Sinovi D.O.O.

    November 2010 - Sopharma AD sets up the wholly owned subsidiary Sopharma Warsaw Sp. z o.o. in Warsaw, the capital of Poland. The newly established company sells Sopharma AD's products in Poland.

    Nov 28, 2011 - The company lists on the Warsaw Stock Exchange.

    Jan 31, 2012 - Sopharma's subsidiary Briz OOD buys 18% of OOO Vivaton Plus, Belarus. By the end of 2012 the total share - direct and indirect - of Sopharma in the company increases to 50%.

    June 14, 2012 - Sopharma buys 6,149 shares in Maritsateks AD and increases its share in the capital of the company to 6.20%.

    July 17, 2012 - Sopharma increases its share in Doverie United Holding AD to 18.7% from 14.97%.

    Jan 23, 2013 - Financial Consultancy Company EOOD sells 4,053,002 shares in Sopharma AD and reduces its share in the company to 9.62%. Donev Investment Holding acquires 2,982,666 shares in Sopharma and increases its share to 26.79%.

    Feb 18, 2013 - Sopharma sells 1.105 million shares in Sopharma Trading AD and reduces its share to 77.77%.

    Mar 21, 2013 - Sopharma acquires 770 new shares in Momina Krepost AD and increases its share in the capital of the company to 50.01%.

    June 2013 - The company reduces its share in Doverie United Holding AD to 9.9% from 18.7%.

    November 2014 - Sopharma AD acquires another 13% in local drug producer Medica AD. In March 2015 Sopharma AD acquires another 6.0% in Medica AD.

    February 2015 - The company's subsidiary Bulgarian Rose-Sevtopolis AD merges into Sopharma AD and ceases to exist.

    Mar 6, 2015 - The company acquires 458,250 new shares in Momina Krepost AD and increases its share in the capital of the company to 80.09%.

    May 2015 - Sopharma AD sells a 75% stake in US-based medical trader Extab Corporation and decreases its share in the company to 5.0%.

    January 2016 - Sopharma AD terminates the preliminary contract for acquisition of Momina Krepost AD, signed in October 2015.

    May 16, 2016 - Sopharma AD increases its share in the capital of Bulgarian company Medika AD to 97.94%

     

    Last updated on Oct 27, 2017.

Management

Executive Board
Pelagiya Stefanova Viyacheva
IR Officer
Board of Directors
Ognian Ivanov Donev
Chairman of the Board and CEO
Vesela Liubenova Stoeva
Deputy-Chairman of the Board
Aleksandar Viktorov Chaushev
Member of the Board
Andrey Liudmilov Breshkov
Member of the Board
Ognian Kirilov Palaveev
Member of the Board

Contacts

Address
16, Iliensko Shose Str.
1220
Sofia, Bulgaria
Telephones

+359 2 405 5652
+359 2 405 5200
+359 2 813 4200
+359 2 813 4253
+359 2 405 5523
+359 2 813 4523
+359 2 405 5553

Fax

+359 2 936 0286
+359 2 813 4141
+359 2 405 5141

Emails

mail@sopharma.bg
ir@sopharma.bg

Websites
www.sopharma.bg

Ownership

Name Direct holding Indirect holding Owner type Country
Telekomplekt Invest AD 20.41 Company Bulgaria
Donev Investments Holding AD 25.14 Company Bulgaria
Other 31.94 Other
Romfarm Company OOD 18.04 Company Bulgaria
Individuals 4.47 Individual

Subsidiaries and affiliates

Name Direct holding Indirect holding Country
Sopharma Ukraine LLC 100.0 Ukraine
Sopharma Trading AD 72.0 Bulgaria
Electroncommerce EOOD 100.0 Bulgaria
Hidroizomat AD 12.0 Bulgaria
Pharmalogistica AD 89.0 Bulgaria
Veta Pharma AD 68.0 Bulgaria
Fito Palauzovo AD 95.0 Bulgaria
Vitamina AD 100.0 Ukraine
Briz OOD 66.13 Latvia
Biopharm Engineering AD 97.15 Bulgaria
Sopharma Warsaw Sp.z.o.o. 100.0 Poland
Sopharma Buildings REIT 40.75 Bulgaria
Unipharm AD 97.0 Bulgaria
Momina Krepost AD 94.0 Bulgaria
Medica AD 98.0 Bulgaria

Products and services

Sopharma AD's product portfolio includes more than 210 generic and branded drugs for human medicine, as well as pharmaceutical active substances in compliance with the international Good Manufacturing Practice (GMP) quality standards. The company's prescription and Over-The-Counter (OTC) drugs for almost all pharmacotherapeutic groups include:

  • solid-dose drugs – tablets and capsules;
  • galenic drugs – suppositories, drops, syrups and ointments;
  • parenteral drugs – injection solutions and lyophilised products.

In 2012 it introduced three new products - Vitamin C- ampoules 2.0 ml and 5.0 ml, Sopral ampoules, Neurelax tablets.

In 2011 the company introduced seven new products: Siafen oral suspension, Siafen gel, Dehidrazid tablets, Talert tablets, Talert syrup and food additives - Bodunoff tablets Neurelaks syrup.

 

Capacity

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Employment

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Market and sales

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Investment plans

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Financial information

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles
Compare
5 / 5 free articles left
Get more for free. Sign up for Basic subscription
Get full access. Upgrade to Premium subscription